RxDoctor Payments Data

Ryann Cowart, MD

Family Medicine · Hayesville, NCNPI 1982970760

Payments from drug & device makers

$347in general payments, 2019–2025

Across 20 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$76
  • Viiv Healthcare Company$45
  • Dexcom, Inc.$35
  • Novo Nordisk$34
  • Boston Scientific$25
  • Abiomed$23
  • plus $108 from 6 others

What the payments were for

  • Food & beverage$347100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$347 in reported general payments places this provider in the 50th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$46,061
Medicare patients
153
Services billed
544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$78,470
Dupixent PenDupilumab16$70,621
TrulicityDulaglutide43$55,068
EliquisApixaban37$39,490
JardianceEmpagliflozin47$38,127
RybelsusSemaglutide15$29,073
MounjaroTirzepatide23$24,454
JanuviaSitagliptin Phosphate16$16,822
FarxigaDapagliflozin Propanediol13$15,305
Tresiba Flextouch U-200Insulin Degludec11$11,283
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$7,737
Lantus SolostarInsulin Glargine,hum.Rec.Anlog37$4,857
Diclofenac Sodium65$2,863
Atorvastatin Calcium242$2,197
Valsartan106$2,000

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$34$107,54275 claims
Lilly USA, LLCTrulicity, Mounjaro$22$79,52266 claims
PfizerEliquis$76$39,49037 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Hayesville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →